Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Monomeric Crystal Structure of the Vaccine Carrier Protein CRM197 and Implications for Vaccine Development

Published

Author(s)

Andrew Lees, Natalia Oganesyan, David Travis Gallagher

Abstract

CRM197 is a genetically detoxified mutant of diphtheria toxin (DT) that is widely used as a carrier protein for conjugate vaccines. Protective immune responses to H. influenzae b, S. pneumoniae, S. Typhi and meningococcal diseases are obtained by coupling CRM to glycans and other components from those pathogens. Wild type DT has been described in two oligomeric forms, a monomer and a domain-swapped dimer. However, all available crystal structures of CRM197 have until now been dimeric, despite 30 years of research and increasing applications of CRM197 in conjugate vaccines. Here we report the crystal structure of a monomeric CRM197, expressed in E. coli. The structure enables detailed comparisons across expression system and oligomeric state, leading to a model for the monomer-dimer transition mechanism and implications for vaccine development.
Citation
Acta Crystallographica Section F - Structural Biology Communications
Volume
79
Issue
4

Keywords

carrier, conjugate vaccine, diphtheria toxin, domain swapping, CRM197, toxoid

Citation

Lees, A. , Oganesyan, N. and Gallagher, D. (2023), Monomeric Crystal Structure of the Vaccine Carrier Protein CRM197 and Implications for Vaccine Development, Acta Crystallographica Section F - Structural Biology Communications, [online], https://doi.org/10.1107/S2053230X23002364, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=934714 (Accessed June 18, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created March 30, 2023, Updated June 5, 2025
Was this page helpful?